IRB e-mail of September 6, 2002
Subject: FYI - Human Subject Research Misadventure
Friday, August 09, 2002
Judge: Hutch didn't reveal study's risk to patient
By David Heath
Seattle Times staff reporter
The Fred Hutchinson Cancer Research Center suffered a major defeat in a lawsuit
yesterday when a federal judge ruled that the center was liable for failing to
inform a 48-year-old woman with breast cancer of the risks in a clinical trial
in which she died.
In a rare summary judgment, District Judge Robert Lasnik concluded that Kathryn
Hamilton would not have enrolled in a clinical trial in 1993 had she been told
the facts.
The judge said a "reasonable jury" could not reach any other conclusion.
Lasnik limited his ruling to the fact that "The Hutch" had failed to tell
Hamilton that a potentially lifesaving drug was not available in a form that she
could tolerate. He left other issues, including the extent of monetary damages
and whether The Hutch misled Hamilton in other ways, to be decided by a jury.
Hamilton's case was brought to light last year in a series in The Seattle Times,
"Uninformed Consent: What patients at 'The Hutch' weren't told about the
experiments in which they died." The Hutch has characterized the series as
"blatantly false."
Hamilton's son, Seattle attorney Chris Addicott, said yesterday, "Since the
Times story came out, it has frustrated and angered me that The Hutch has
consistently tried to maintain that it did nothing wrong, in the face of such
overwhelming evidence to the contrary.
"With this ruling, the court has swept aside The Hutch's arguments and
vindicated what I've been saying all along, ruling as a matter of law that
nobody would willingly subject themselves to an otherwise lethal dose of
chemotherapy knowing that they would be denied the one drug they were told might
save them."
The Hutch did not comment on the judge's ruling in Hamilton's case yesterday.
The Hutch noted instead that the judge dismissed some but not all of the claims
made in another lawsuit against the center brought by the family of Becky
Wright, a leukemia patient who died in another experiment, Protocol 126.
"In both lawsuits, we intend to defend the remaining claims vigorously and
expect to show that the center and its physicians acted in the best interest of
their patients," its statement said.
The Hutch had tried to get the case dismissed on the grounds that Hamilton's
husband, Allan Berman of Spokane, filed the lawsuit after the statute of
limitations had passed.
Lasnik ruled against The Hutch's motion and said a jury should decide that
issue.
In his 11-page decision, Lasnik said that The Hutch violated Washington's
informed-consent law by telling Hamilton that a drug intended to prevent serious
damage from high-dose chemotherapy was available in intravenous form. But it was
not.
If The Hutch had told her the drug was unavailable, "Hamilton would not have
agreed to the treatment which ultimately killed her," the judge wrote.
The Hutch was trying to find the highest dose it could safely give of two
chemotherapy drugs for breast-cancer patients getting stem-cell transplants. In
its first attempt, The Hutch saw two of its first four patients die from the
lethal effects of this chemotherapy.
In Hamilton's cancer trial, Protocol 681, Dr. William Bensinger added two other
drugs to try to prevent such lethal side effects. Hamilton was told that if she
threw up the pills - which she had done often in past cancer treatments - she
would be given the two drugs intravenously.
However, two months before Hamilton enrolled in the trial, the supply of the
intravenous drug had been cut off. A Hutch memo told researchers to change the
informed-consent statements to reflect this. However, the informed-consent
statement given to Hamilton said the IV drug was available.
Hamilton repeatedly vomited the pills and died from toxic side effects of
chemotherapy 44 days after entering the hospital. Without the experimental
treatment, Hamilton was expected to live another year or two.
The Hutch has argued that Hamilton's not getting the drug didn't matter because
it proved ineffective.
"This argument misses the point," Lasnik wrote. She was entitled to informed
consent.
The Hutch also argued that Hamilton was so desperate that she would have
participated in the cancer trial even if she had known that the IV drug wasn't
available.
Lasnik said there was no evidence to support this argument and concluded that
Hamilton would not have enrolled in the trial if she had been properly informed.
Hamilton also was given "false and misleading" information about how many
patients had been enrolled and died before her in the cancer trial, Lasnik
wrote.
The day before Hamilton entered the hospital, a doctor told her that "there have
been no deaths" among the 15 patients in her trial.
In fact, there were 31 patients and seven had died by that day, Lasnik wrote,
including one who suffered serious organ damage from the high-dose chemotherapy.
The lawsuit is set for trial on Sept. 16.
Issues for the jury will include whether The Hutch misled Hamilton by misstating
the number of deaths in her trial; whether it misled her about the result of
research done on the drug's effectiveness; and when Hamilton's husband first
suspected The Hutch was negligent.